Back to results
US 2021/0261690 A9Published application
Method of Generating Anti-Linaclotide Antibodies and Uses Thereof
AssigneeIronwood Pharmaceuticals, Inc.
InventorsWilmin Bartolini, Marco Kessler
Life of this patent
Estimating the term…
Abstract
The invention provides a method for producing anti-linaclotide antibodies or antigen fragments thereof and uses thereof.
Claims35
A antibody or antigen-binding fragment thereof that binds to an epitope of linaclotide.
A method of producing anti-linaclotide antibodies comprising:
- a) conjugating linaclotide to a carrier protein;
- b) immunizing an animal with the protein conjugated linaclotide to produce an immune response and thereby generate anti-linaclotide antibodies;
- and
- c) harvesting the anti-linaclotide antibodies from the immunized animal.
1 more element
A method of detecting an antibody or antigen-binding fragment of linaclotide in a biological specimen which comprises:
- a) contacting the specimen with linaclotide or epitope thereof, wherein the linaclotide or epitope thereof is conjugated or bound to a detection label, tag, or substrate, thereby forming a complex between linaclotide and the antibody or antigen-binding fragment thereof of linaclotide;
- and
- b) assaying for the presence of the complex.
A method for qualifying a manufacturing batch of linaclotide comprising;
- a) providing a batch of linaclotide;
- b) contacting at least a portion of the batch of linaclotide with anti-linaclotide antibodies or antigen-binding fragment, thereby forming a complex between linaclotide and anti-linaclotide antibodies or antigen-binding fragments thereof;
- c) quantifying the presence of said complex;
- and
- d) correlating the quantity of said complex with a known quantity of complex formed between a reference batch of linaclotide and anti-linaclotide antibodies or antigen-binding fragment thereof.
2 more elements
Dependencies are inferred from the claim text.